Tianfeng Securities released a research report on April 11 stating that it gave Changchun Hi-Tech (000661.SZ) a purchase rating. The main reasons for the rating include: 1) the growth hormone sector is progressing steadily, and new businesses are growing rapidly; 2) increasing investment in R&D and continuously improving the R&D network; 3) the research pipeline continues to advance, and the clinical progress of many new products is progressing smoothly. (Mainichi Keizai Shimbun)
天风证券4月11日发布研报称，给予长春高新（000661.SZ）买入评级。评级理由主要包括：1）生长激素板块稳步推进，新业务快速成长；2）加大研发投入力度，不断完善研发布局；3）在研管线持续推进，多项新产品临床进展顺利。（每日经济新闻）
Tianfeng Securities released a research report on April 11 stating that it gave Changchun Hi-Tech (000661.SZ) a purchase rating. The main reasons for the rating include: 1) the growth hormone sector is progressing steadily, and new businesses are growing
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.